Actinium Pharmaceuticals, Inc. (ATNM)

NYSE · Pharmaceutical Preparations · Inc. DE

What they're doing

Not enough recent activity to summarise.

Signals, last 12 months

  1. Material 8-K filing
    Filed 8-K disclosing director or officer change
  2. Material 8-K filing
    Filed 8-K disclosing director or officer change

Insider transactions

DateInsiderRoleCodeSharesPriceValue
2026-09-02Chell Jeffrey W.directorA61,6000$0
2026-09-02Steinhart Richard IdirectorA62,8000$0
2026-09-02SETH SANDESHdirectorA1,027,2740$0
2026-09-02SETH SANDESHdirectorA753,6000$0
2026-09-02Almenoff June SheriedirectorA18,0000$0
2026-09-02Shetty AjitdirectorA61,6000$0
2026-09-02Nicholson, C. DaviddirectorA62,8000$0
2025-08-18SETH SANDESHdirectorF120,9001.71$206,739

Federal contracts

No federal contract actions on record for this recipient mapping.

Lobbying

No federal lobbying filings on record for this client mapping.

Public attention

No Wikipedia pageview data linked to this company.

Recent filings

  • 2026-09-10 3
  • 2026-09-10 3
  • 2026-09-04 4
  • 2026-09-04 4
  • 2026-09-04 4
  • 2026-09-04 4
  • 2026-09-04 4
  • 2026-09-04 4
  • 2026-08-14 8-K
  • 2026-08-07 10-Q
  • 2026-06-18 8-K
  • 2026-05-29 8-K
  • 2026-05-08 10-Q
  • 2026-03-30 10-K
  • 2026-03-26 8-K/A
  • 2026-02-13 8-K
  • 2025-11-26 8-K
  • 2025-11-14 10-Q
  • 2025-11-05 ARS
  • 2025-11-05 DEF 14A